Carcinoid Lung Tumors Medication

Updated: Jul 25, 2022
  • Author: Mary C Mancini, MD, PhD, MMM; Chief Editor: Jeffrey C Milliken, MD  more...
  • Print

Medication Summary

Surgical resection is the first line of treatment. Everolimus may be considered for unresectable, progressive neuroendocrine tumors.


Antineoplastic Agents

Class Summary

Although surgery is the first line of treatment, everolimus may be considered for progressive, unresectable neuroendocrine tumors (NET) of lung origin.

Everolimus (Afinitor)

Everolimus is an mTOR kinase inhibitor (mammalian target of rapamycin, a serine-threonine kinase, downstream of the PI3K/AKT pathway, which is dysregulated in several human cancers. It is indicated for progressive, well-differentiated, non-functional NET of lung origin that are unresectable, locally advanced or metastatic.